Workup for Alkaline Phosphatase of 643 U/L with Elevated LFTs
Start with transabdominal ultrasound immediately to assess for biliary ductal dilatation and gallstones, as this alkaline phosphatase level strongly suggests cholestatic liver disease requiring urgent evaluation for biliary obstruction. 1
Initial Laboratory Assessment
Before imaging, confirm the elevated alkaline phosphatase is hepatic in origin by checking:
- Gamma-glutamyl transpeptidase (GGT): An elevated GGT confirms the ALP elevation originates from the liver rather than bone, kidney, or other sources 1
- Fractionated bilirubin: Elevated conjugated bilirubin indicates hepatocellular disease or cholestasis 2
- Review the pattern: ALP of 643 U/L (approximately 5-6 times upper normal limit) with disproportionate elevation compared to ALT/AST defines cholestatic predominance 1
Imaging Algorithm
First-Line: Ultrasound Abdomen
Transabdominal ultrasound is the appropriate initial imaging modality for evaluating elevated ALP suspected to be hepatic in origin 1. This will identify:
- Intra- or extrahepatic biliary ductal dilatation
- Cholelithiasis or choledocholithiasis (most common cause of extrahepatic biliary obstruction)
- Gallbladder abnormalities
- Hepatic parenchymal changes
If Ultrasound Shows Biliary Dilatation
Proceed to MRI abdomen with MRCP (magnetic resonance cholangiopancreatography) 1. This is the most useful imaging modality for:
- Evaluating the etiology of biliary obstruction
- Noninvasive assessment of intra- and extrahepatic bile ducts
- Triaging patients to interventions like ERCP, stenting, or biopsy
- Detecting malignant obstruction, strictures, or choledocholithiasis
If Ultrasound is Negative but ALP Remains Elevated
MRI abdomen with MRCP remains indicated for persistently elevated ALP with negative ultrasound, as sustained ALP elevation significantly correlates with choledocholithiasis that may be missed on ultrasound 1
Alternative: CT Abdomen/Pelvis with IV Contrast
While less sensitive than MRI/MRCP for bile duct evaluation, contrast-enhanced CT can help define:
- Site and etiology of obstruction
- Coexistent complications
- Pelvic sources of obstruction (lymphadenopathy)
- However, ultrasound remains first-line 1
Core Laboratory Panel for Cholestatic Disease
Beyond confirming hepatic origin, obtain a liver aetiology screen 3:
Core panel:
- Hepatitis B surface antigen (HBsAg)
- Hepatitis C antibody
- Autoimmune markers: Anti-mitochondrial antibody (for primary biliary cholangitis)
- Immunoglobulin G level (elevated in autoimmune hepatitis)
- Ferritin and transferrin saturation (for hemochromatosis if >45%)
Consider extended testing if no clear cause:
- Review medication history (drug-induced cholestasis is common)
- Assess for inflammatory bowel disease history (suggests primary sclerosing cholangitis)
- Evaluate for infiltrative diseases: sarcoidosis, amyloidosis, hepatic metastases 1
Critical Pitfalls to Avoid
- Don't assume bone origin: Always confirm with GGT before attributing elevated ALP to bone disease 1
- Don't delay imaging: An ALP of 643 U/L requires prompt evaluation for biliary obstruction, which can lead to cholangitis or hepatic dysfunction if untreated
- Don't skip ultrasound: Even if planning advanced imaging, ultrasound provides rapid, radiation-free assessment and may identify patients needing urgent ERCP 1
- Don't ignore clinical context: Jaundice, abdominal pain, fever, or weight loss mandate immediate referral and expedited workup 3
Specialist Referral Indications
Refer to gastroenterology/hepatology if:
- Dilated bile ducts requiring intervention
- Positive autoimmune markers (anti-mitochondrial antibody, elevated IgG)
- Evidence of chronic cholestatic disease (primary biliary cholangitis, primary sclerosing cholangitis)
- No clear etiology after initial workup 3
The key is rapid, systematic evaluation starting with ultrasound, confirming hepatic origin with GGT, and advancing to MRI/MRCP based on initial findings to prevent complications from untreated biliary obstruction.